Men embrace PSA test, but are they overly enthusiastic?
March 1st 2004White River Junction, VT--The often-controversial PSA test has now achieved broad public acceptance as a screening tool, according to a recent study. But only a minority of primary care physicians are following published guidelines for administering the test, according to another, separate study.
Investigational PDE-5 inhibitor comparable to sildenafil, study shows
February 18th 2004A phase II study comparing the onset of action of two oral phosphodiesterase-type 5 inhibitors?TA-1790, an investigational agent and sildenafil citrate (Viagra) showed comparable results, according to VIVUS, Inc., maker of TA-1790.
In-office test found useful adjunct to cystoscopy
February 15th 2004Las Vegas--An in-office bladder cancer test is significantly more sensitive than cytology at detecting the disease in high-risk patients, report community-based urologists from Anchorage, AK. The test also appears to be effective at determining risk of recurrence in patients with known disease, at least in the short term.
Allografts vs. mesh: Experts debate their pros, cons
February 15th 2004Las Vegas--Which material is better for pelvic floor reconstruction: allografts or synthetic mesh? If you ask two of urology's leading pelvic floor surgeons, each will provide a very different answer. Gary Leach, MD, a proponent of allografts, and Shlomo Raz, MD, a proponent of synthetic slings, made their points known in a verbal face-off at the AUA Western Section annual meeting here
Data on obesity-PCa link mount, but conflict
February 15th 2004Las Vegas--Obesity in prostate cancer patients is associated withhigher-grade tumors, cancer recurrence, and more aggressive disease, recentstudies have shown. The research has prompted some urologists to suggestusing body mass index (BMI) as a marker for early screening and treatment.Others suggest that further studies should be undertaken to determine ifweight loss may, in fact, lower prostate cancer risk.
Data reveal shift in prostate Ca treatment choices
February 15th 2004Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data from the CaPSURE database.
Dr. Kuo joins urology department at Thomas Jefferson
February 5th 2004Urologist Ramsay L. Kuo, MD, has joined the department of urology at Thomas Jefferson University Hospital, Philadelphia, with an appointment as assistant professor of urology, Jefferson Medical College of Thomas Jefferson University.
Group establishes guidelines for drug studies of relapsed prostate Ca patients
February 5th 2004A group of three leading cancer centers has developed guidelines to determine which prostate cancer patients at risk for relapse should participate in a clinical trial and which compounds are appropriate in these studies.
NIDDK invites applications on research into epidemiology of interstitial cystitis
February 5th 2004The National Institute of Diabetes and Digestive and Kidney Diseases has announced a request for applications (RFA) for a study entitled, "Interstitial Cystitis/Painful Bladder Syndrome: Epidemiology" (RFA-DK-04-009).
Anticholinergic drug effective in treating severe overactive bladder, study shows
February 5th 2004A sustained-release anticholinergic drug provides appears to be beneficial in the reduction of urge incontinence for patients with either severe or moderate symptoms of overactive bladder, according to results of a study published in the February issue of The Journal of Urology (2004; 171:752-6).
Testosterone replacement therapy not linked to prostate cancer, analysis finds
February 5th 2004There is no causal relationship between testosterone replacement and prostate cancer or heart disease risk, according to a retrospective analysis by researchers at Beth Israel Deaconess Medical Center, published last week in The New England Journal of Medicine (2004; 350:482-92).
How to diagnose and treat late-onset hypogonadism
February 1st 2004The last few years have witnessed an enormous interest in androgen replacement therapy for late-onset hypogonadism-also known as "androgen deficiency in the aging male." As urologists, we frequently deal with sexual dysfunction and are seen as experienced on issues of prostate health.
Lap nephroureterectomy: Mid-term results show promise
February 1st 2004Montreal--Laparoscopic nephroureterectomy is becoming a widely utilized option in the surgical treatment of upper tract transitional cell carcinoma. As more centers accrue larger series with longer follow-up, assessment of surgical as well as oncologic results is possible and necessary.
How to make a high-quality poster using PowerPoint
February 1st 2004All of us see great clinical cases from time to time and make valuableobservations. Often there is an opportunity to present this material asa poster at scientific meetings. Until recently, the production of a high-qualityscientific poster required the use of an outside graphic arts firm at acost of more than $1,000.
Varicocele repair offers potential to help infertile men
February 1st 2004Varicocele is a common clinical finding, present in approximately 15%of adult men. When the patient with a varicocele visits a urologist, itis often due to testicular discomfort or fertility-related concerns. Atthe 2003 meeting of the American Society for Reproductive Medicine, bothof these issues were addressed and are discussed in this issue of UrologyTimes.
Natural conception possible after varicocele repair
February 1st 2004San Antonio--Repair of clinically significant varicoceles may resultin nearly a 25% chance of natural conception, even in men who do not demonstratesignificant improvements in their postoperative seminal parameters, accordingto University of Iowa researchers.
Polishing the 'gold standard' in vasovasostomy
February 1st 2004San Antonio--Biomaterial wraps are a promising adjunct for vasovasostomy,according to results of an animal study that incorporated a biomaterialmatrix and a sealant into the conventional three-suture anastomosis. Researcherscalled this "polishing the gold standard" because of the highpatency rate of the standard procedure.
Take advantage of new tax rules when filing returns
February 1st 2004Our income tax law, the Internal Revenue Code, turned 90 in 2003. Whatstarted as a 400-page tax bill when Woodrow Wilson signed it into law in1913 now contains more than 55,000 pages. In fact, last year, Congress passedand the president quickly signed into law a $330 billion, 10-year tax cutplan-The Jobs and Growth Tax Relief Reconciliation Act of 2003. That billboth added to the page count and made a significant impact on the tax billsof many physician practices.
Cancer patients' semen is preserved late, used little
February 1st 2004San Antonio--A retrospective study of men with cancer who elected to cryopreservetheir sperm because of cancer therapy found that 20% of men had alreadyreceived one or more cycles of chemotherapy. The recognized toxic effectsof chemotherapy and radiation on sperm cells make this a questionable practice